Note 5 - Stockholders' Deficit (Details) |
3 Months Ended |
|---|---|
|
Sep. 30, 2018
$ / shares
shares
| |
| Warrants outstanding and exercisable, beginning | shares | 1,740,790 |
| Warrants exchanged | shares | (40,000) |
| Warrants outstanding and exercisable, ending | shares | 1,700,790 |
| Warrants outstanding and exercisable, weighted average exercise price, beginning | $ / shares | $ 2.03 |
| Warrants exchanged, weighted average exercise price | $ / shares | 2.00 |
| Warrants outstanding and exercisable, weighted average exercise price, ending | $ / shares | $ 2.03 |
| Warrants outstanding and exercisable, remaining contractual term | 5 months 19 days |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Represents the weighted average exercise price of warrants or rights. No definition available.
|
| X | ||||||||||
- Definition The remaining contractual term of each class of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|